Hemoglobin Levels Declining in CKD Patients on ESAs
Hemoglobin (Hb) levels in non-dialysis CKD patients treated with erythropoiesis-stimulating agents (ESAs) have been on the decline.
Hemoglobin (Hb) levels in non-dialysis CKD patients treated with erythropoiesis-stimulating agents (ESAs) have been on the decline.
Proton pump inhibitors (PPIs) taken concurrently with phosphate binders may increase phosphate control in hemodialysis (HD) patients, according to researchers who presented their data at the National Kidney Foundation’s 2010 Spring Clinical Meetings..
Administration of ergocalciferol (vitamin D2) to anemic hemodialysis (HD) patients receiving erythropoietin (EPO) may decrease EPO requirements, suggest data presented at the National Kidney Foundation 2010 Spring Clinical Meetings.
The phosphorus content of a typical American diet significantly increases levels of fibroblast growth factor-23 (FGF-23), a pilot study suggests.
ORLANDO, Fla.—Patients converted from in-center conventional hemodialysis (ICHD) to in-center nocturnal hemodialysis (NHD) have improvements in serum phosphorus levels and blood pressure (BP) control, according to two studies of the same cohort of 418 patients.
ORLANDO, Fla.—Acute kidney injury (AKI), acute renal failure , and the need for dialysis are common complications in critically ill patients with pandemic H1N1 Influenza A (pH1N1), and are associated with an increased risk of death, according to Canadian researchers.
ORLANDO, Fla.—Correcting iron deficiency in non-dialysis CKD patients lowers platelet counts and improves erythropoiesis, researchers reported here at the National Kidney Foundation’s 2010 Spring Clinical Meetings.
Although kidneys infected with hepatitis C virus (HCV) were 2.6 times more likely than HCV-free donor kidneys to be discarded than used for transplantation, HCV-positive patients may well derive some benefit from receiving these organs, according to a report in the American Journal of Transplantation (online ahead of print).
Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD).
Mice that consumed approximately 14 shelled walnuts per day for two months exhibited significantly smaller, slower-growing prostate tumors after 18 weeks than did mice that ingested an equal amount of fat from soybean oil instead of walnuts.